Dr. Matthew J Mccarty, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 220 Bmh Cancer Center, Maryville, TN 37804 Phone: 865-977-1065 Fax: 865-982-8538 |
Dr. S Spence Mccachren, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 220 Bmh Cancer Center, Maryville, TN 37804 Phone: 865-977-1065 Fax: 865-982-8538 |
News Archive
House Research Institute (HRI) is recruiting patients for a Phase II clinical trial to test a medication that may slow the progression of Neurofibromatosis Type-2, commonly referred to as NF2.
Courtyard Group today responded after reviewing details of the Ontario Auditor General's report on the eHealth initiative.
In patients with type 2 diabetes, silent cerebral infarction (SCI)—small areas of brain damage caused by injury to small blood vessels—signals an increased risk of progressive kidney disease and kidney failure, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).
Encision Inc., a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, reported its financial results for its first fiscal quarter ended June 30, 2010.
› Verified 1 days ago